Industry Category
Business Keywords
Company Description
Vaxil Bio Ltd. is a pioneering biotechnology research company dedicated to developing innovative cancer treatments in the field of immuno-oncology. Based in the prestigious Weizmann Science Park in Rehovot, Israel, Vaxil Bio Ltd. is committed to advancing the frontiers of medical science. The company's primary address is Pinchas Sapir 3, Weizmann Science Park, Rehovot, 7414001, IL.
Vaxil Bio Ltd.'s lead product, Immucin, has achieved significant recognition by receiving Orphan Drug Status from both the FDA and EMA. This milestone underscores the potential of Vaxil Bio Ltd.'s research to address critical unmet needs in cancer therapy. Vaxil Bio Ltd. is leveraging its patented VaxHit platform to expand its portfolio of cancer immunotherapy products, utilizing the signal peptide domain of MUC1, which is present in a vast majority of cancers.
Vaxil Bio Ltd. is dedicated to improving patient outcomes through groundbreaking research and development. The company's commitment to innovation positions it as a key player in the biotechnology landscape. We encourage the management of Vaxil Bio Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and capabilities.
Key Personnel / Employees
Compare Companies Side by Side
Compare Vaxil Bio Ltd. with 3 companies in Biotechnology-Research
| Comparison Field |
Vaxil Bio Ltd.Main Company |
Poseida Therapeutics...View Profile |
Alloy Therapeutics,...View Profile |
Strike Pharma ABView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2017 | 2020 |
|
Company Size
|
— | 201-500 | 51-200 | 2-10 |
|
City
|
San Diego, California | Boston, Massachusetts | ||
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
11 Total Skills
Biotechnology
Immuno-oncology
Cancer Treatment
Pharmaceuticals
Medical Research
FDA
Orphan Drug Status
Signal Peptide Domains
Multiple Myeloma
Cancer Vaccines
Immunotherapy
|
21 Total
1 Common
20 Unique
Match
9%
Common Skills:
Immuno-oncology
Unique Skills:
Adoptive Cell Therapy
Allogeneic
CAR-T cells
Cas-CLOVER™
Cell Therapy
Cytotoxic T Lymphocytes
+14
|
12 Total
12 Unique
Unique Skills:
ASO
Biologics Discovery
Biotech
Bispecific Antibodies
Chimeric Antigen Receptors
Company Creation
+6
|
4 Total
1 Common
3 Unique
Match
9%
Common Skills:
Immuno-oncology
Unique Skills:
CAR-T
Drug Development
Personalized medicine
|
4
Total Companies2014
Oldest Founded1
Countries46
Unique SkillsSimilar Companies
Other organizations in the same industry
NeoGenix Laboratoire Sdn Bhd
Biotechnology-ResearchNeoGenix Laboratoire is leading the biomedical revolution in precision health.
Biochrom Ltd.
Biotechnology-ResearchExperts in Amino Acid Analysers, UV-Vis Spectrophotometers and Microplate Instrumentation
Novogene Europe
Biotechnology-ResearchLeading Edge Genomic Services & Solutions
Alternative Company Names
This company is also known as